ID: ALA4452822

Max Phase: Preclinical

Molecular Formula: C18H19FN6O7S

Molecular Weight: 482.45

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CNc1nc2c(N)ncnc2n1[C@@H]1O[C@H](COC(=O)c2ccc(S(=O)(=O)F)cc2)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C18H19FN6O7S/c1-21-18-24-11-14(20)22-7-23-15(11)25(18)16-13(27)12(26)10(32-16)6-31-17(28)8-2-4-9(5-3-8)33(19,29)30/h2-5,7,10,12-13,16,26-27H,6H2,1H3,(H,21,24)(H2,20,22,23)/t10-,12-,13-,16-/m1/s1

Standard InChI Key:  PKHVDJQAKQNAAY-XNIJJKJLSA-N

Associated Targets(Human)

HSPA2 Tchem Heat shock-related 70 kDa protein 2 (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 482.45Molecular Weight (Monoisotopic): 482.1020AlogP: -0.42#Rotatable Bonds: 6
Polar Surface Area: 191.78Molecular Species: NEUTRALHBA: 13HBD: 4
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.45CX Basic pKa: 3.49CX LogP: 0.22CX LogD: 0.22
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.26Np Likeness Score: 0.43

References

1. Pettinger J, Carter M, Jones K, Cheeseman MD..  (2019)  Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72.,  62  (24): [PMID:31725295] [10.1021/acs.jmedchem.9b01709]

Source